{
  "id": "SCR-LIP-000628",
  "statement": "Diabetes is reported less frequently in lipedema and lipedema-like peripheral fat distribution than in comparison groups, although adiposity matching is limited.",
  "claim_type": "clinical_association",
  "context": {
    "population": "US women >=20y (NHANES)",
    "condition": "lipedema",
    "exposure": "lipedema-like phenotype (LTR >90th pct)",
    "comparator": "controls (LTR <=90th pct)",
    "outcome": "HOMA-IR, NLR",
    "scope": "cross-sectional, n=283 phenotype / 3550 controls"
  },
  "knowledge_state": "emerging",
  "evidence_confidence": "low",
  "evidence": [
    {
      "ref": "DOI:10.7759/cureus.104222",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2026,
      "amato_authored": true,
      "note": "Exploratory cross-sectional population study directly examines whether a peripheral/gynoid (lipedema-like) fat distribution confers metabolic protection, reporting lower HOMA-IR and reduced diabetes prevalence with dose-response; supports t",
      "title": "Exploring the Immunological Shield Hypothesis: A Population-Based Exploration of Phenotypic Divergence Between Lipedema and Celiac Disease Autoimmunity",
      "authors": "Amato et al.",
      "journal": "Cureus",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": false,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "verified by verifier; quote not verbatim-grounded. The article explicitly reports HOMA-IR median 44.2% lower (1.35 vs 2.42; p<0.001) and NLR 7.6% lower (1.96 vs 2.12; p=0.012) in the lipedema phenotype group, matching the statement's number",
        "date": "2026-06-10"
      },
      "quote": "fenótipo lipedema fortemente protetor contra diabetes (prevalência 1,8% vs 8,1%; OR 0,21; IC95% 0,08-0,51; p<0,001)",
      "extraction_confidence": "high",
      "stance_in_source_claim": "supporting",
      "finding": "In a population-based NHANES analysis, the DXA-defined lipedema phenotype was associated with lower diabetes prevalence (1.8% vs 8.1%; OR 0.21; 95%CI 0.08-0.51; p<0.001).",
      "from_claims": [
        "SCR-LIP-000027"
      ]
    },
    {
      "ref": "DOI:10.1515/hmbci-2017-0076",
      "stance": "supporting",
      "study_design": "case_series",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "low",
      "year": 2018,
      "amato_authored": false,
      "note": "The article describes lipedema as a distinct disorder frequently misdiagnosed as obesity or lymphedema, with characteristic fat distribution, staging, inheritance pattern, and a metabolic profile differing from obesity; supports the affirma",
      "title": "Lipedema: friend and foe",
      "authors": "Torre et al.",
      "journal": "Hormone Molecular Biology and Clinical Investigation",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article directly reports a chart review of 46 women with lipedema, mean BMI 35.3±1.7 kg/m², with diabetes 2%, dyslipidemia 11.7%, hypertension 13%, notes that lifestyle change does not reduce lipedema fat, and explicitly states healthca",
        "date": "2026-06-10"
      },
      "quote": "Perfil cardiometabólico PROTETOR apesar de IMC obeso médio 35,3±1,7 kg/m²: diabetes apenas 2% (vs. ~10% mulheres NHANES idade-pareada); dislipidemia 11,7% (vs. 33,5%); hipertensão 13% (vs. 32,4% mulheres 40-59 anos)",
      "extraction_confidence": "moderate",
      "stance_in_source_claim": "supporting",
      "finding": "Chart review of 46 women with lipedema (mean BMI 35.3): diabetes 2% (vs ~10% in age-matched NHANES women), dyslipidemia 11.7% (vs 33.5%), hypertension 13% (vs 32.4%).",
      "from_claims": [
        "SCR-LIP-000259"
      ]
    },
    {
      "title": "Lipedema: A Disease Triggered by M2 Polarized Macrophages?",
      "ref": "DOI:10.3390/biomedicines13030561",
      "stance": "supporting",
      "study_design": "review",
      "n": null,
      "risk_of_bias": "unknown",
      "grade": "very_low",
      "year": 2025,
      "amato_authored": false,
      "quote": "Diabetes tipo 2: incidência MENOR em pacientes com lipedema vs. controles femininos BMI-matched — efeito 'protetor' da deposição adiposa subcutânea gluteofemoral",
      "extraction_confidence": "high",
      "note": "The review explicitly reports lower type 2 diabetes incidence and a favorable metabolic profile in lipedema despite high BMI, describing the gluteofemoral fat deposition as 'protective' — directly affirmative to the question regarding metab",
      "verification": {
        "method": "dual-model",
        "verifier_model": "anthropic/claude-sonnet-4-6",
        "primary_model": "anthropic/claude-opus-4.8",
        "quote_grounded": true,
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "The article explicitly states the metabolic paradox (BMI ≥30 frequent but insulin sensitivity preserved, normal BP, no hepatic steatosis, normal adiponectin/leptin/CRP) and directly mentions 'Diabetes tipo 2: incidência MENOR em pacientes c",
        "date": "2026-11-17"
      },
      "stance_in_source_claim": "supporting",
      "finding": "Review reports lower type 2 diabetes incidence in lipedema than in BMI-matched female controls, plus preserved insulin sensitivity and normal CRP, attributed to protective gluteofemoral fat.",
      "from_claims": [
        "SCR-LIP-000573"
      ]
    },
    {
      "ref": "DOI:10.1590/1677-5449.202600752",
      "stance": "supporting",
      "study_design": "cross_sectional",
      "n": 4986,
      "risk_of_bias": "moderate",
      "year": 2026,
      "title": "Peripheral fat distribution, the lipedema-associated phenotype, and lower prevalence of cardiometabolic disease in women: a cross-sectional study (NHANES 2011-2018)",
      "authors": "Amato ACM, Amato JLS, Benitti DA",
      "grade": "low",
      "_prov": {
        "grade_source": "bib_curated"
      },
      "quote": "Diabetes 465 0.17 (0.12-0.25) <0.001",
      "finding": "In 4,986 NHANES women, the DXA peripheral fat phenotype was associated with lower diabetes prevalence (1.8% vs 13.6%; OR 0.17, 95%CI 0.12-0.25, adjusted for body-fat category, age, race/ethnicity and smoking; diabetes = self-report or HbA1c ≥6.5%); cross-sectional.",
      "extraction_confidence": "high",
      "verification": {
        "method": "single-model (Claude Code subagent)",
        "verifier_model": "claude-sonnet (subagent, fresh context)",
        "primary_model": "claude-opus-5-5 (session)",
        "quote_grounded": true,
        "date": "2026-11-20",
        "stance_agreed": true,
        "faithful": true,
        "verifier_stance": "supporting",
        "verdict": "verified",
        "reason": "Table 3 OR and Table 1 prevalences match; adiposity only partly controlled (body-fat category), consistent with the proposition's caveat."
      },
      "added": "2026-11-20",
      "quote_location": "Table 3 (main effect OR per component, adjusted for body fat category, age, race/ethnicity, smoking)",
      "note": "Overlaps the NHANES 2011-2014 participants of DOI:10.7759/cureus.104222 (same group, similar phenotype): not an independent sample for diabetes.",
      "translation_ref": "DOI:10.1590/1677-5449.202600751",
      "amato_authored": true
    }
  ],
  "relations": [],
  "gaps": "",
  "curators": [
    {
      "name": "Alexandre C. M. Amato",
      "orcid": "0000-0003-4008-4029",
      "role": "lead_curator"
    }
  ],
  "created": "2026-11-20",
  "updated": "2026-11-20",
  "license": "CC-BY-4.0",
  "consolidated_from": [
    "SCR-LIP-000027",
    "SCR-LIP-000259",
    "SCR-LIP-000573"
  ],
  "questions_consolidated": [
    "SQ-LIP-000010"
  ],
  "provenance": {
    "method": "consolidation (R-CLM-19)",
    "store_key": "G-00240",
    "models": {
      "primary": "claude-opus-5.5 (Claude Code subagent, 1 repair round)",
      "verifier": "claude-sonnet (Claude Code subagent, fresh context)",
      "mode": "agent"
    }
  },
  "history": [
    {
      "date": "2026-11-20",
      "event": "created_by_consolidation",
      "detail": "general proposition consolidated from SQ-LIP-000010"
    },
    {
      "date": "2026-11-20",
      "event": "evidence added",
      "detail": "finding from DOI:10.1590/1677-5449.202600752 (supporting)"
    }
  ],
  "statement_pt": "O diabetes é relatado com menos frequência no lipedema e na distribuição periférica de gordura semelhante à do lipedema do que em grupos de comparação, embora o pareamento por adiposidade seja limitado.",
  "answers_questions": [
    {
      "id": "SQ-LIP-000010",
      "role": "supporting",
      "question": "Does a lipedema-like (peripheral/gynoid) fat distribution protect against cancer or metabolic disease?",
      "url": "https://scientificclaims.org/q/SQ-LIP-000010.html"
    }
  ],
  "url": "https://scientificclaims.org/c/SCR-LIP-000628.html"
}